解决妊娠期糖尿病诊断困境:需要一项随机对照治疗试验
该视角文章指出,妊娠期糖尿病(GDM)的诊断标准在国际及各国内部仍存分歧,部分人主张全面采用IADPSG标准并认为进一步临床试验不必要甚至不伦理;但作者担忧该标准大幅增加GDM诊断人数及其对医疗资源和个人影响,回顾IADPSG共识起源并指出其局限性,质疑支持其血糖阈值的临床与成本效果数据,主张诊断标准应基于不同母体血糖阈值下对治疗的反应,可能需要国际多中心治疗试验。
要点
- GDM诊断标准仍存分歧,IADPSG标准全面采用存在争议。
- IADPSG标准大幅增加GDM诊断人数,带来资源和个体影响担忧。
- 诊断标准应基于不同血糖阈值下治疗反应,需国际多中心试验。
核心结论
- GDM诊断标准的采纳应基于不同母体血糖诊断阈值下对治疗的反应,而非仅凭现行共识。
- 可能需要一项国际多中心治疗试验来解决诊断标准争议。
研究设计与样本
- 本文为视角文章,回顾IADPSG共识的起源并指出其局限性。
- 文章质疑常被引用来支持IADPSG血糖阈值的临床和成本效果数据。
主要发现
- GDM诊断标准在科学和医学界内部及国家间持续存在分歧。
- 部分人认为全面采用IADPSG标准后进一步临床试验不必要甚至不伦理。
- 采用IADPSG标准会大幅增加被诊断为GDM的女性数量,影响医疗资源和个人。
- IADPSG共识在识别不良妊娠结局风险女性方面存在一些较少人知的局限性。
临床怎么用
- 临床采纳GDM诊断标准时应考虑不同血糖阈值下治疗的有效性证据。
- 需关注IADPSG标准下GDM诊断人数增加对资源和个体的影响。
局限性
- 本文为视角文章,未提供新的试验数据。
- 文章指出支持IADPSG血糖阈值的临床和成本效果数据受到质疑。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The diagnosis of and criteria for gestational diabetes mellitus (GDM) continue to divide the scientific and medical community, both between and within countries. Many argue for universal adoption of the International Association of the Diabetes and Pregnancy Study Groups (IADPSG) criteria and feel that further clinical trials are unjustified and even unethical. However, there are concerns about the large increase in number of women who would be diagnosed with GDM using these criteria and the subsequent impact on health care resources and the individual. This Perspective reviews the origins of the IADPSG consensus and points out some of its less well-known limitations, particularly with respect to identifying women at risk for an adverse pregnancy outcome. It also questions the clinical and cost-effectiveness data often cited to support the IADPSG glycemic thresholds. We present the argument that adoption of diagnostic criteria defining GDM should be based on response to treatment at different diagnostic thresholds of maternal glycemia. This will likely require an international multicenter trial of treatment.
引用
- Bilous RW, Jacklin PB, Maresh MJ, et al. Resolving the Gestational Diabetes Diagnosis Conundrum: The Need for a Randomized Controlled Trial of Treatment. Diabetes Care. 2021. PMID: 33741696. doi:10.2337/dc20-2941
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。